Malin Corporation plc
ISE:MLC.IR
Overview | Financials
Company Name | Malin Corporation plc |
Symbol | MLC.IR |
Currency | EUR |
Price | 5.8 |
Market Cap | 109,557,940 |
Dividend Yield | 0% |
52-week-range | 3.84 - 6.45 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Darragh Fergal Lyons |
Website | https://malinplc.com |
An error occurred while fetching data.
About Malin Corporation plc
Malin Corporation plc, through its subsidiaries, operates in the life sciences industry in Ireland and the United States. It offers life-saving cell and gene therapies for patients with high unmet medical need; medicines to address unmet needs in cancer, infection, and autoimmune diseases; and treatment of recurrent vulvovaginal candidiasis, an
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD